These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27260268)

  • 1. The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index.
    Korkmaz L; Baştuğ O; Ozdemir A; Korkut S; Karaca C; Akin MA; Gunes T; Kurtoglu S; Ozturk MA
    Curr Eye Res; 2017 Jan; 42(1):88-97. PubMed ID: 27260268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: Which newborn and when?
    Ozturk MA; Korkmaz L
    Int Ophthalmol; 2019 Sep; 39(9):1921-1930. PubMed ID: 30229439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.
    Filippi L; Cavallaro G; Fiorini P; Daniotti M; Benedetti V; Cristofori G; Araimo G; Ramenghi L; La Torre A; Fortunato P; Pollazzi L; la Marca G; Malvagia S; Bagnoli P; Ristori C; Dal Monte M; Bilia AR; Isacchi B; Furlanetto S; Tinelli F; Cioni G; Donzelli G; Osnaghi S; Mosca F
    BMC Pediatr; 2010 Nov; 10():83. PubMed ID: 21087499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet mass index can be a reliable marker in predicting the prognosis of retinopathy of prematurity in very preterm infants.
    Korkmaz L; Baştuğ O; Özdemir A; Korkut S; Karaca Ç; Akın MA; Öztürk MA
    Pediatr Neonatol; 2018 Oct; 59(5):455-463. PubMed ID: 29223489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.
    Filippi L; Cavallaro G; Berti E; Padrini L; Araimo G; Regiroli G; Bozzetti V; De Angelis C; Tagliabue P; Tomasini B; Buonocore G; Agosti M; Bossi A; Chirico G; Aversa S; Pasqualetti R; Fortunato P; Osnaghi S; Cavallotti B; Vanni M; Borsari G; Donati S; Nascimbeni G; la Marca G; Forni G; Milani S; Cortinovis I; Bagnoli P; Dal Monte M; Calvani AM; Pugi A; Villamor E; Donzelli G; Mosca F
    BMC Pediatr; 2017 Jul; 17(1):165. PubMed ID: 28709412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between mean platelet volume and retinopathy of prematurity.
    Tao Y; Dong Y; Lu CW; Yang W; Li Q
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1791-4. PubMed ID: 25749720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia is associated with severe retinopathy of prematurity.
    Cakir B; Liegl R; Hellgren G; Lundgren P; Sun Y; Klevebro S; Löfqvist C; Mannheimer C; Cho S; Poblete A; Duran R; Hallberg B; Canas J; Lorenz V; Liu ZJ; Sola-Visner MC; Smith LE; Hellström A
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.
    Filippi L; Cavallaro G; Bagnoli P; Dal Monte M; Fiorini P; Donzelli G; Tinelli F; Araimo G; Cristofori G; la Marca G; Della Bona ML; La Torre A; Fortunato P; Furlanetto S; Osnaghi S; Mosca F
    J Pediatr; 2013 Dec; 163(6):1570-1577.e6. PubMed ID: 24054431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral propranolol in early stages of retinopathy of prematurity.
    Bancalari A; Schade R; Muñoz T; Lazcano C; Parada R; Peña R
    J Perinat Med; 2016 Jul; 44(5):499-503. PubMed ID: 26845715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update in the Treatment of Retinopathy of Prematurity.
    Bancalari A; Schade R
    Am J Perinatol; 2022 Jan; 39(1):22-30. PubMed ID: 32544962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term Refractive Effects of Propranolol Hydrochloride Prophylaxis on Retinopathy of Prematurity in Very Preterm Newborns.
    Korkmaz L; Karaca C; Akin MA; Bastug O; Sahiner M; Ozdemir A; Gunes T; Ozturk MA; Kurtoglu S
    Curr Eye Res; 2018 Feb; 43(2):213-217. PubMed ID: 29135357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice.
    Dal Monte M; Casini G; la Marca G; Isacchi B; Filippi L; Bagnoli P
    Exp Eye Res; 2013 Jun; 111():27-35. PubMed ID: 23528535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Thrombocyte Parameters in Retinopathy of Prematurity Development.
    Özkaya D
    Int J Clin Pract; 2022; 2022():7518533. PubMed ID: 35685577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Propranolol in Preventing Severe Retinopathy of Prematurity: A Comprehensive Systematic Review and Meta-Analysis.
    Shafique MA; Haseeb A; Uddin MMN; Asghar B; Chaudhry ER; Raqib MA; Ali SMS; Mustafa MS
    Am J Ophthalmol; 2024 Mar; 259():141-150. PubMed ID: 37979602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
    Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
    Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II.
    Autrata R; Krejcírová I; Senková K; Holoušová M; Doležel Z; Borek I
    Eur J Ophthalmol; 2012; 22(5):687-94. PubMed ID: 22669848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease.
    Menke MN; Framme C; Nelle M; Berger MR; Sturm V; Wolf S
    BMC Ophthalmol; 2015 Mar; 15():20. PubMed ID: 25886603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial.
    Bührer C; Erdeve Ö; Bassler D; Bar-Oz B
    BMJ Open; 2018 Jul; 8(7):e021749. PubMed ID: 29982217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Propranolol: A New Treatment for Infants with Retinopathy of Prematurity?
    Bührer C; Bassler D
    Neonatology; 2015; 108(1):49-52. PubMed ID: 25968340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.